Table 3 Post hoc analysis of scores of screening tests and in-depth neuropsychological evaluations reported for all groups of patients.
Variable | PD | MSA | PSP | VP | p-value PD versus MSA | p-value PD versus PSP | p-value PD versus VP | p-value MSA versus PSP | p-value MSA versus VP | p-value PSP versus VP |
|---|---|---|---|---|---|---|---|---|---|---|
MMSE | 27.2 ± 2.3 | 26.2 ± 2.1 | 26.2 ± 3.5 | 26.8 ± 2.9 | 0.052 | 0.54 | 0.99 | 0.95 | 0.43 | 0.96 |
FAB | 14.4 ± 2.7 | 13.8 ± 2.2 | 11.6 ± 3.9 | 13.5 ± 3.0 | 0.60 | <0.0001 | 0.21 | 0.25 | 1.00 | 0.27 |
MoCA | 23.4 ± 3.6 | 21.9 ± 3.7 | 20.5 ± 4.9 | 21.8 ± 3.7 | 0.13 | 0.003 | 0.057 | 0.97 | 1.00 | 0.92 |
CoMDA | 65.1 ± 7.2 | 61.9 ± 6.4 | 58.1 ± 10.6 | 62.1 ± 8.2 | 0.060 | 0.0005 | 0.10 | 0.94 | 1.00 | 0.62 |
WCST | 73.2 ± 36.7 | 68.9 ± 34.2 | 90.0 ± 22.1 | 77.5 ± 35.5 | ||||||
Stroop test E | 5.2 ± 7.6 | 3.2 ± 4.6 | 11.3 ± 8.4 | 11.3 ± 9.1 | 0.98 | 0.00031 | <0.0001 | 0.003 | 0.001 | 1.00 |
Stroop test T | 20.6 ± 13.0 | 25.6 ± 13.5 | 29.7 ± 26.4 | 22.8 ± 20.5 | ||||||
TMT-A | 44.3 ± 46.6 | 61.7 ± 35.6 | 70.0 ± 65.5 | 79.8 ± 88.7 | 0.016 | 0.17 | 0.010 | 0.99 | 1.00 | 1.00 |
TMT-B | 126.3 ± 100.2 | 172.2 ± 79.8 | 161.6 ± 107.3 | 186.1 ± 123.6 | 0.014 | 0.42 | 0.024 | 0.96 | 1.00 | 1.00 |
TMT B-A | 89.1 ± 81.8 | 112.3 ± 64.5 | 123.3 ± 87.1 | 132.1 ± 99.3 | 0.12 | 0.20 | 0.09 | 1.00 | 1.00 | 1.00 |
RAVLT-e | 43.1 ± 10.2 | 44.6 ± 9.8 | 38.8 ± 8.3 | 40.9 ± 8.3 | 0.96 | 0.08 | 0.54 | 0.10 | 0.43 | 0.93 |
RAVLT-delayed recall | 8.7 ± 3.2 | 9.3 ± 3.1 | 7.5 ± 2.9 | 7.8 ± 2.8 | 0.80 | 0.16 | 0.28 | 0.08 | 0.14 | 1.00 |
ROCF-c | 29.3 ± 6.5 | 26.2 ± 6.1 | 19.3 ± 9.3 | 26.5 ± 8.1 | 0.022 | <0.0001 | 0.11 | 0.28 | 0.95 | 0.014 |
ROCF-dr | 14.9 ± 5.7 | 14.8 ± 6.3 | 11.8 ± 6.9 | 13.8 ± 4.5 | ||||||
CF | 43.5 ± 9.5 | 38.9 ± 9.7 | 30.9 ± 6.7 | 37.5 ± 8.6 | 0.18 | <0.0001 | 0.003 | 0.023 | 1.00 | 0.044 |
PF | 32.5 ± 10.5 | 25.2 ± 9.8 | 19.3 ± 7.6 | 25.8 ± 9.4 | 0.006 | <0.0001 | 0.002 | 0.33 | 1.00 | 0.10 |